Triclofos: Difference between revisions
No edit summary |
m (Protected "Triclofos": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 69: | Line 69: | ||
{{Hypnotics and sedatives}} | {{Hypnotics and sedatives}} | ||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
[[Category:Prodrugs]] | [[Category:Prodrugs]] | ||
[[Category:Organochlorides]] | [[Category:Organochlorides]] | ||
[[Category:Drug]] | [[Category:Drug]] |
Latest revision as of 17:20, 20 August 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C2H4Cl3O4P |
Molar mass | 229.383 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Triclofos |
Articles |
---|
Most recent articles on Triclofos |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Triclofos at Clinical Trials.gov Clinical Trials on Triclofos at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Triclofos
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Triclofos Discussion groups on Triclofos Directions to Hospitals Treating Triclofos Risk calculators and risk factors for Triclofos
|
Healthcare Provider Resources |
Causes & Risk Factors for Triclofos |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Triclofos is a sedative drug used rarely for treating insomnia, usually as a second-line treatment after other drugs have failed. Triclofos may cause dependence and should not be withdrawn suddenly. This drug should only be used for the short term relief of severe insomnia and should not be mixed with alcohol or other depressant drugs. Patients should not drive or use machinery after taking triclofos.
Triclofos is a prodrug which is metabolised in the liver into the active drug trichloroethanol. This delayed action means that the half-life of triclofos is fairly long and it may cause drowsiness the next day. Trichloroethanol may cause liver damage and triclofos should not be used for extended periods.
Side effects
Side effects may include: headache, rash, dizziness, flatulence, confusion, nightmares, dependence, diarrhoea, constipation, nausea, vomiting, abdominal pain, and ataxia.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Sedatives
- Prodrugs
- Organochlorides
- Drug